DK0984963T3 - Hidtil ukendte forbindelser - Google Patents
Hidtil ukendte forbindelserInfo
- Publication number
- DK0984963T3 DK0984963T3 DK98924708T DK98924708T DK0984963T3 DK 0984963 T3 DK0984963 T3 DK 0984963T3 DK 98924708 T DK98924708 T DK 98924708T DK 98924708 T DK98924708 T DK 98924708T DK 0984963 T3 DK0984963 T3 DK 0984963T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- hitherto unknown
- unknown compounds
- sec
- date
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229940123344 GPR antagonist Drugs 0.000 abstract 1
- 102000007466 Purinergic P2 Receptors Human genes 0.000 abstract 1
- 108010085249 Purinergic P2 Receptors Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal (AREA)
- Valve-Gear Or Valve Arrangements (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702002A SE9702002D0 (sv) | 1997-05-28 | 1997-05-28 | Novel compounds |
| PCT/SE1998/000940 WO1998054180A1 (en) | 1997-05-28 | 1998-05-18 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0984963T3 true DK0984963T3 (da) | 2001-06-05 |
Family
ID=20407125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98924708T DK0984963T3 (da) | 1997-05-28 | 1998-05-18 | Hidtil ukendte forbindelser |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6162808A (da) |
| EP (1) | EP0984963B1 (da) |
| JP (1) | JP2002501528A (da) |
| AT (1) | ATE200489T1 (da) |
| AU (1) | AU7681198A (da) |
| DE (1) | DE69800699T2 (da) |
| DK (1) | DK0984963T3 (da) |
| ES (1) | ES2156444T3 (da) |
| GR (1) | GR3036195T3 (da) |
| PT (1) | PT984963E (da) |
| SE (1) | SE9702002D0 (da) |
| WO (1) | WO1998054180A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE213242T1 (de) * | 1997-11-21 | 2002-02-15 | Astrazeneca Uk Ltd | Neue verbindungen, welche antagonisten sind für p2-purinorezeptor 7-transmembran (tm) g-protein gekoppelte rezeptoren |
| US7696168B2 (en) * | 2000-04-21 | 2010-04-13 | Tufts Medical Center, Inc. | G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| AU2001257169C1 (en) | 2000-04-21 | 2011-06-16 | Tufts Medical Center, Inc. | G-protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| US20030151980A1 (en) * | 2002-02-13 | 2003-08-14 | Isador Farash | Color referenced multi-time watch |
| AUPS160602A0 (en) | 2002-04-08 | 2002-05-16 | University Of Queensland, The | Therapeutic method |
| AU2002952086A0 (en) * | 2002-10-16 | 2002-11-07 | The University Of Queensland | Treatment of osteoarthritis |
| EP1814911A2 (en) * | 2004-11-04 | 2007-08-08 | New England Medical Center Hospitals, Inc. | G protein coupled receptor agonists and antagonists and methods of use |
| US7589213B2 (en) | 2007-04-27 | 2009-09-15 | Old David W | Therapeutic substituted lactams |
| US8592413B2 (en) | 2008-05-15 | 2013-11-26 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| CN103159641A (zh) * | 2011-12-14 | 2013-06-19 | 天津泰普药品科技发展有限公司 | 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法 |
| EP2881390A1 (en) | 2013-12-04 | 2015-06-10 | Sanofi | Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolase |
| CN106045937B (zh) * | 2016-06-21 | 2019-04-16 | 杭州诺维和医药技术有限公司 | 一种{2-[2-(2-氨基-4-噻唑基)-乙酰基氨基]-4-噻唑基}-乙酸的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2099868C (en) * | 1991-01-31 | 2002-04-02 | Thomas Richard Belliotti | Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| IT1277373B1 (it) * | 1995-07-28 | 1997-11-10 | Consiglio Nazionale Ricerche | Impiego di composti agonisti o antagonisti dei recettori purinici p2 per la prevenzione della citotossicita' da glutammato |
-
1997
- 1997-05-28 SE SE9702002A patent/SE9702002D0/xx unknown
-
1998
- 1998-05-18 AU AU76811/98A patent/AU7681198A/en not_active Abandoned
- 1998-05-18 DK DK98924708T patent/DK0984963T3/da active
- 1998-05-18 PT PT98924708T patent/PT984963E/pt unknown
- 1998-05-18 WO PCT/SE1998/000940 patent/WO1998054180A1/en not_active Ceased
- 1998-05-18 EP EP98924708A patent/EP0984963B1/en not_active Expired - Lifetime
- 1998-05-18 JP JP50056799A patent/JP2002501528A/ja active Pending
- 1998-05-18 US US09/091,187 patent/US6162808A/en not_active Expired - Fee Related
- 1998-05-18 AT AT98924708T patent/ATE200489T1/de not_active IP Right Cessation
- 1998-05-18 ES ES98924708T patent/ES2156444T3/es not_active Expired - Lifetime
- 1998-05-18 DE DE69800699T patent/DE69800699T2/de not_active Expired - Fee Related
-
2001
- 2001-07-10 GR GR20010401043T patent/GR3036195T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6162808A (en) | 2000-12-19 |
| ES2156444T3 (es) | 2001-06-16 |
| SE9702002D0 (sv) | 1997-05-28 |
| DE69800699T2 (de) | 2001-09-06 |
| AU7681198A (en) | 1998-12-30 |
| EP0984963A1 (en) | 2000-03-15 |
| GR3036195T3 (en) | 2001-10-31 |
| JP2002501528A (ja) | 2002-01-15 |
| DE69800699D1 (de) | 2001-05-17 |
| EP0984963B1 (en) | 2001-04-11 |
| WO1998054180A1 (en) | 1998-12-03 |
| ATE200489T1 (de) | 2001-04-15 |
| PT984963E (pt) | 2001-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9702651D0 (sv) | Novel compounds | |
| ATE331726T1 (de) | Adenine-derivate | |
| BR0015963A (pt) | Compostos de uréia antagonistas receptor muscarìnico, composições farmacêuticas compreendendo tais compostos e método de preparação destes compostos | |
| EP0903349A3 (en) | CCR-3 receptor antagonists | |
| DE69532162D1 (de) | Cannabinoid-rezeptor-antagonisten | |
| ATE270663T1 (de) | Trizyklische 1-benzylpyrazol-3- carbonsäurederivate als cannabinoidrezeptorantagonisten | |
| DK0760811T3 (da) | Imidazolderivater som histaminreceptor H3-modulatorer | |
| NO983002L (no) | Vitronectin-reseptor-antagonister | |
| ES2160525A1 (es) | Derivados de la 4-aroilpiperidina antagonistas de los receptores ccr-3 | |
| NO20032905D0 (no) | Nye benzodiazepiner og beslektede heterocykliske derivater som er anvendelige som orexinreseptorantagonister | |
| ES2158813A1 (es) | Sales cuaternarias de piperidina antagonistas del receptor ccr-3 | |
| DK0984963T3 (da) | Hidtil ukendte forbindelser | |
| PT1007523E (pt) | Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao | |
| SE9702794D0 (sv) | New compounds | |
| DE50008020D1 (de) | Substituierte pyrrolidin-2,3,4-trion-derivate wirksam als nmda-rezeptor-antagonisten | |
| NO963331L (no) | 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister | |
| ES2172939T3 (es) | Nuevos compuestos que son antagonistas de receptores acoplados a proteina g de 7-transmembrana (tm) de p2-purinoceptores. | |
| IT1270612B (it) | Derivati eterociclo-condensatori di morfinoidi | |
| TR199901380A2 (xx) | Di-ya da triazo-spiro$4,5] dekan t�revleri | |
| NO20000654D0 (no) | 1,3-dioxolo/4,5-H//2,3/benzodiazepinderivater som AMPA/KAINAT reseptorinhibitorer | |
| DE69526738D1 (de) | Endothelin-rezeptor-antagonisten | |
| ECSP972049A (es) | Derivados de lactama |